[5-fluorouracil: metabolism and current indications in digestive cancer treatment].
Aparicio
Thomas
T
Service d'Hépato-Gastroentérologie, Hôpital Bichat-Claude-Bernard, Paris. aparicio@bch.ap-hop-paris.fr
Ducreux
Michel
M
Chaussade
Stanislas
S
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000378:metabolism* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004067:Digestive System Neoplasms / Q000188:drug therapy*; D004351:Drug Resistance; D005472:Fluorouracil / Q000009:adverse effects / Q000378:metabolism* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D011878:Radiotherapy
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil
5-fluorouracile: données sur le métabolisme et place actuelle dans le traitement des cancers digestifs.